Lajos Pusztai
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Lajos Pusztai
Sep 25, 2024, 13:30 |
Blog
Matteo Dugo: Neoadjuvant atezolizumab plus chemotherapy in TNBC
Matteo Dugo shared a post on LinkedIn, about recent paper published in Clinical Cancer Research:…
Sep 24, 2024, 12:30 |
Societies
11 ESMO24 presentations published on NEJM
At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…
Aug 31, 2024, 16:48 |
Blog
Tess O'Meara: Discussing mIF and machine learning imagine processing on breast cancer with Lajos Pustzai
Tess O'Meara, Hematology/Oncology Fellow at Dana-Farber Cancer Institute, shared a post on X: "Grateful to…
Aug 18, 2024, 07:29 |
Blog
,
Opinion
Paolo Tarantino: Do all patients with TNBC need 5 neoadjuvant drugs + 1 year of IO?
Paolo Tarantino shared a post on X about recent paper by Marleen Kok et al., titled…
Aug 12, 2024, 12:38 |
Insight
Francisco J. Esteva: The NeoSTEEP initiative
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared…
Aug 2, 2024, 01:47 |
Blog
Sergio Cifuentes Canaval: Neoadjuvant Chemo-Immuno for ER+ HER- breast cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent…
Jul 27, 2024, 22:17 |
Insight
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522
Erika Hamilton shared on X: "This commentary led by Marleen Kok highlights all the pertinent…
Jul 26, 2024, 00:03 |
Blog
Elisa Agostinetto: Must-read by Marleen Kok on the limitations of KEYNOTE-522
Elisa Agostinetto shared on X: "Out in JCO a must-read by Marleen Kok on the…
Jul 25, 2024, 08:58 |
Insight
Marleen Kok: How do we get from one-size-fits-all to personalized treatment for TNBC
Marleen Kok, Breast Medical Oncologist at the Netherlands Cancer Institute, shared on X: "Today from…
Jul 25, 2024, 08:37 |
Blog
Marco Mariani: Our latest publication on positive results reporting among immunotherapy trials in breast cancer, 2004-2023
Marco Mariani, Resident at San Raffaele Scientific Institute, posted on X: "Excited to share our…
Jul 24, 2024, 00:59 |
Insight
Luca Licata: The fate of immunotherapy trials in breast cancer
Marco Mariani, Resident in Medical Oncology at San Raffaele Scientific Institute, shared a post on X…
Jun 8, 2024, 03:12 |
Blog
Roberta Albany: Thank you for the opportunity to be a part of the new research presented at ASCO24
Roberta Albany, Founder and CEO at Cancer In The Know, shared a post on their…
Oct 28, 2023, 01:25 |
Blog
The Breast Cancer Research Foundation (BCRF) announced $60.2 million commitment to fund breast cancer research in 2023-2024 - Yale Cancer Center
Yale Cancer Center recently posted on LinkedIn. "The Breast Cancer Research Foundation (BCRF) Scientific Advisory Board…
All:
13
Posts:
1 - 100
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube